About this briefing

About this briefing

Medtech innovation briefings summarise the published evidence and information available for individual medical technologies. The briefings provide information to aid local decision‑making by clinicians, managers and procurement professionals.

Medtech innovation briefings aim to present information and critically review the strengths and weaknesses of the relevant evidence, but contain no recommendations and are not formal NICE guidance.

Development of this briefing

This briefing was developed for NICE by the Birmingham and Brunel Consortium. The interim process and methods statement sets out the process NICE uses to select topics, and how the briefings are developed, quality‑assured and approved for publication.

Project team

Birmingham and Brunel Consortium

Medical Technologies Evaluation Programme, NICE

Peer reviewers and contributors

  • Laurence Blake, Research Fellow, University of Birmingham

  • Rui Duarte, Research Fellow, University of Birmingham

  • Neil O'Connell, Senior Lecturer, Brunel University

Specialist commentators

The following specialist commentators provided comments on a draft of this briefing:

  • Michael Flynn, Medical Consultant, Kent and Canterbury Hospital

  • Vicky Ruszala, Specialist Pharmacist, Diabetes and Endocrinology, North Bristol NHS Trust

  • Lesley Drummond, Lead Diabetes Nurse, Birmingham Children's Hospital

  • Theresa Smyth, Nurse Consultant in Diabetes, University Hospital Birmingham NHS Foundation Trust

Declarations of interest

No relevant interests declared.


© National Institute for Health and Care Excellence, 2016. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not‑for‑profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.

ISBN: 978-1-4731-1667-2